BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9271408)

  • 1. Functional differences between Stat3alpha and Stat3beta.
    Schaefer TS; Sanders LK; Park OK; Nathans D
    Mol Cell Biol; 1997 Sep; 17(9):5307-16. PubMed ID: 9271408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms.
    Park OK; Schaefer LK; Wang W; Schaefer TS
    J Biol Chem; 2000 Oct; 275(41):32244-9. PubMed ID: 10915797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a constitutively active Stat3 protein.
    Barboza JA; Wang S; Schaefer TS
    Mol Biol Rep; 2004 Mar; 31(1):13-21. PubMed ID: 15040450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat3 and G-CSF-induced myeloid differentiation.
    Chakraborty A; Tweardy DJ
    Leuk Lymphoma; 1998 Aug; 30(5-6):433-42. PubMed ID: 9711905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
    Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes.
    Ng IH; Ng DC; Jans DA; Bogoyevitch MA
    Biochem J; 2012 Oct; 447(1):125-36. PubMed ID: 22799634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 and 15 activate Stat3alpha in human T lymphocytes.
    Nielsen M; Nordahl M; Svejgaard A; Odum N
    Cytokine; 1998 Oct; 10(10):735-8. PubMed ID: 9811525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Src activates the DNA binding and transcriptional activity of Stat3 molecules: serine 727 is not required for transcriptional activation under certain circumstances.
    Schaefer LK; Wang S; Schaefer TS
    Biochem Biophys Res Commun; 1999 Dec; 266(2):481-7. PubMed ID: 10600528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock.
    Yoo JY; Huso DL; Nathans D; Desiderio S
    Cell; 2002 Feb; 108(3):331-44. PubMed ID: 11853668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3beta, a distinct isoform from STAT3.
    Zhang HX; Yang PL; Li EM; Xu LY
    Int J Biochem Cell Biol; 2019 May; 110():130-139. PubMed ID: 30822557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization.
    Sasse J; Hemmann U; Schwartz C; Schniertshauer U; Heesel B; Landgraf C; Schneider-Mergener J; Heinrich PC; Horn F
    Mol Cell Biol; 1997 Aug; 17(8):4677-86. PubMed ID: 9234724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727.
    Ng J; Cantrell D
    J Biol Chem; 1997 Sep; 272(39):24542-9. PubMed ID: 9305919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer.
    Bharadwaj U; Kasembeli MM; Eckols TK; Kolosov M; Lang P; Christensen K; Edwards DP; Tweardy DJ
    Cancers (Basel); 2014 Sep; 6(4):2012-34. PubMed ID: 25268166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino acid residues immediately carboxyl-terminal to the tyrosine phosphorylation site contribute to interleukin 6-specific activation of signal transducer and activator of transcription 3.
    Inoue M; Minami M; Matsumoto M; Kishimoto T; Akira S
    J Biol Chem; 1997 Apr; 272(14):9550-5. PubMed ID: 9083098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription.
    Caldenhoven E; van Dijk TB; Solari R; Armstrong J; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    J Biol Chem; 1996 May; 271(22):13221-7. PubMed ID: 8675499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a tyrosine phosphorylated, DNA binding Stat3beta dimer in bacteria.
    Becker S; Corthals GL; Aebersold R; Groner B; Müller CW
    FEBS Lett; 1998 Dec; 441(1):141-7. PubMed ID: 9877182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.
    Huang Y; Qiu J; Dong S; Redell MS; Poli V; Mancini MA; Tweardy DJ
    J Biol Chem; 2007 Nov; 282(48):34958-67. PubMed ID: 17855361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2).
    Schaefer LK; Ren Z; Fuller GN; Schaefer TS
    Oncogene; 2002 Mar; 21(13):2058-65. PubMed ID: 11960378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling.
    Hu G; Witzig TE; Gupta M
    PLoS One; 2013; 8(7):e67851. PubMed ID: 23861822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
    Turkson J; Bowman T; Garcia R; Caldenhoven E; De Groot RP; Jove R
    Mol Cell Biol; 1998 May; 18(5):2545-52. PubMed ID: 9566874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.